FNI Venture Capital
VC Fund
Ipswich, United Kingdom
FNI Venture Capital is an investment arm of Renate Nixdorf Verwaltungsgesellschaft mbH.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries FNI Venture Capital invests in
Stages FNI Venture Capital invests in
Countries FNI Venture Capital invests in
Investment Focus
Industry
- Medical 2 (67%)
- Health Care 2 (67%)
- Pharmaceutical 2 (67%)
- Life Science 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
Country
- Germany 1 (33%)
- United Kingdom 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Antenova
|
Antenova, Ltd. engages in the design, development, and supply of standard and custom antennas, and radio frequency antenna modules. Its products are used in mobile handsets, adapters, portable devices, laptop computers, and wireless devices. Antenova, Ltd. was incorporated in 1999 and is headquartered in Stow-cum-Quy, the United Kingdom. It hasdesign, and sales and support centers in Taipei, Taiwan; Chicago, Illinois; and Shanghai, China, as well as manufacturing operations in Taiwan and China. | $10M / Jun 06, 2007 | |
Spinal Cord Therapeutics GmbH
|
Spinal Cord Therapeutics GmbH develops treatments for spinal cord injury. Spinal Cord Therapeutics focuses on the treatment of traumatic injury to the central nervous system. | $14M / Series A / Sep 19, 2005 | |
De Novo Pharmaceuticals
|
De Novo Pharmaceuticals is an emerging computational drug design company. De Novo Pharmaceuticals uses its proprietary computational software for drug design to create novel, patentable lead molecules as candidates for drug development. De Novo's proprietary algorithms can convert information from structural genomics and medicinal chemistryrapidly into new chemical designs, maximising value within a pharmaceutical partner's research portfolio. De Novo's drug discovery partners include British Biotechnology, Aventis Pharmaceuticals and NV Organon. | $22M / Series B / Jul 26, 2001 |
Co-Investors
The Cambridge Gateway Fund
2 deals together
Artemis
1 deal together
Avlar BioVentures
1 deal together
BioMedPartners
1 deal together
CLS Holdings
1 deal together
Global Life Science Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does FNI Venture Capital invest in?
FNI Venture Capital invests primarily in Medical, Health Care and Pharmaceutical startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did FNI Venture Capital last invest?
The most recent investment recorded for FNI Venture Capital closed in Jun 2007. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
